Valuation: SMS Pharmaceuticals Limited

Market Cap 4.45TCr 46Cr 41Cr 38Cr 35Cr 66Cr 66Cr 460.3Cr 178.28Cr 2.27TCr 174.26Cr 170.5Cr 7.3TCr P/E 2025
27.3x
P/E 2026 33.6x
Enterprise Value 4.77TCr 50Cr 44Cr 41Cr 38Cr 70Cr 71Cr 493.32Cr 191.07Cr 2.44TCr 186.76Cr 182.72Cr 7.83TCr EV / Sales 2025
2.75x
EV / Sales 2026 4.31x
Free-Float
23.41%
Yield 2025
0.19%
Yield 2026 0.11%
1 day+0.06%
1 week+7.20%
Current month+27.79%
1 month+33.16%
3 months+26.21%
6 months+17.67%
Current year+53.10%
1 week 445
Extreme 445
494.4
1 month 349.95
Extreme 349.95
494.4
Current year 293.55
Extreme 293.55
494.4
1 year 240.45
Extreme 240.45
494.4
3 years 111.95
Extreme 111.95
494.4
5 years 54.5
Extreme 54.5
494.4
10 years 23.55
Extreme 23.55
494.4
Manager TitleAgeSince
Chief Executive Officer 66 30/08/1990
Director of Finance/CFO - 13/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 30/08/1990
Director/Board Member 38 05/06/2020
Director/Board Member 48 29/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%+7.20% - - 46Cr
+0.12%+0.81%+13.81%+64.78% 4.64TCr
+1.09%+0.36%+39.50%+107.67% 3.73TCr
+2.00%+3.78%+18.12%+99.54% 1.25TCr
+0.05%+0.37%-7.29%+18.68% 1.18TCr
0.00%0.00%+18.72%+139.63% 897.09Cr
-1.34%-2.73%+27.67%+37.52% 709.04Cr
-2.07%-2.75%+17.20%+202.97% 700.76Cr
+1.43%+2.22%+43.10%-14.21% 729.19Cr
-2.45%-0.59%-51.49%+4.53% 498.93Cr
Average -0.11%+0.16%+13.26%+73.46% 1.59TCr
Weighted average by Cap. +0.32%+0.54%+19.51%+79.15%

Financials

2025 2026
Net sales 782.75Cr 8.17Cr 7.17Cr 6.77Cr 6.17Cr 12Cr 12Cr 81Cr 31Cr 399.89Cr 31Cr 30Cr 1.29TCr 888.64Cr 9.27Cr 8.14Cr 7.68Cr 7Cr 13Cr 13Cr 92Cr 36Cr 453.99Cr 35Cr 34Cr 1.46TCr
Net income 69Cr 72.13L 63.3L 59.78L 54.48L 1.02Cr 1.03Cr 7.15Cr 2.77Cr 35Cr 2.71Cr 2.65Cr 113.51Cr 101.99Cr 1.06Cr 93.38L 88.19L 80.37L 1.5Cr 1.52Cr 11Cr 4.09Cr 52Cr 4Cr 3.91Cr 167.46Cr
Net Debt 269.27Cr 2.81Cr 2.47Cr 2.33Cr 2.12Cr 3.97Cr 4Cr 28Cr 11Cr 137.56Cr 11Cr 10Cr 442.11Cr 319.08Cr 3.33Cr 2.92Cr 2.76Cr 2.51Cr 4.71Cr 4.74Cr 33Cr 13Cr 163.01Cr 12Cr 12Cr 523.89Cr
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,617
Date Price Change Volume
25/26/25 ₹474.85 +0.06% 45,708
24/26/24 ₹474.55 -1.71% 19,896
23/26/23 ₹482.80 -0.03% 44,864
22/26/22 ₹482.95 +3.54% 74,560
21/26/21 ₹466.45 +5.31% 79,722

Annual profits - Rate of surprise